142 related articles for article (PubMed ID: 21520098)
21. High expression of CXCR4 and CXCR7 predicts poor survival in gallbladder cancer.
Yao X; Zhou L; Han S; Chen Y
J Int Med Res; 2011; 39(4):1253-64. PubMed ID: 21986127
[TBL] [Abstract][Full Text] [Related]
22. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer.
Iwakiri S; Mino N; Takahashi T; Sonobe M; Nagai S; Okubo K; Wada H; Date H; Miyahara R
Cancer; 2009 Jun; 115(11):2580-93. PubMed ID: 19309748
[TBL] [Abstract][Full Text] [Related]
23. Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer.
D'Alterio C; Consales C; Polimeno M; Franco R; Cindolo L; Portella L; Cioffi M; Calemma R; Marra L; Claudio L; Perdonà S; Pignata S; Facchini G; Cartenì G; Longo N; Pucci L; Ottaiano A; Costantini S; Castello G; Scala S
Curr Cancer Drug Targets; 2010 Nov; 10(7):772-81. PubMed ID: 20578990
[TBL] [Abstract][Full Text] [Related]
24. Close correlation between CXCR4 and VEGF expression and frequent CXCR7 expression in rhabdomyosarcoma.
Miyoshi K; Kohashi K; Fushimi F; Yamamoto H; Kishimoto J; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2014 Sep; 45(9):1900-9. PubMed ID: 25086956
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
26. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
[TBL] [Abstract][Full Text] [Related]
27. A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients.
D'Alterio C; Avallone A; Tatangelo F; Delrio P; Pecori B; Cella L; Pelella A; D'Armiento FP; Carlomagno C; Bianco F; Silvestro L; Pacelli R; Napolitano M; Iaffaioli RV; Scala S
Int J Cancer; 2014 Jul; 135(2):379-90. PubMed ID: 24375277
[TBL] [Abstract][Full Text] [Related]
28. Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours.
Kajtazi Y; Kaemmerer D; Sänger J; Schulz S; Lupp A
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2481-2493. PubMed ID: 31451931
[TBL] [Abstract][Full Text] [Related]
29. Expression of CXCR7 in colorectal adenoma and adenocarcinoma: Correlation with clinicopathological parameters.
Sherif MF; Ismail IM; Ata SMS
Ann Diagn Pathol; 2020 Dec; 49():151621. PubMed ID: 32949893
[TBL] [Abstract][Full Text] [Related]
30. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G
Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239
[TBL] [Abstract][Full Text] [Related]
31. Expression of the CXCR4 and CXCR7 in renal cancers; can "the orphan receptor" predict the mortality?
Floranović MP; Petrović AR; Veličković LJ
Ann Diagn Pathol; 2021 Dec; 55():151829. PubMed ID: 34563828
[TBL] [Abstract][Full Text] [Related]
32. Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease.
Wehler T; Wolfert F; Schimanski CC; Gockel I; Herr W; Biesterfeld S; Seifert JK; Adwan H; Berger MR; Junginger T; Galle PR; Moehler M
Oncol Rep; 2006 Dec; 16(6):1159-64. PubMed ID: 17089032
[TBL] [Abstract][Full Text] [Related]
33. Astrocytic expression of the CXCL12 receptor, CXCR7/ACKR3 is a hallmark of the diseased, but not developing CNS.
Puchert M; Pelkner F; Stein G; Angelov DN; Boltze J; Wagner DC; Odoardi F; Flügel A; Streit WJ; Engele J
Mol Cell Neurosci; 2017 Dec; 85():105-118. PubMed ID: 28889992
[TBL] [Abstract][Full Text] [Related]
34. Chemokine receptor expression on integrin-mediated stellate projections of prostate cancer cells in 3D culture.
Kiss DL; Windus LC; Avery VM
Cytokine; 2013 Oct; 64(1):122-30. PubMed ID: 23921147
[TBL] [Abstract][Full Text] [Related]
35. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
Zabel BA; Wang Y; Lewén S; Berahovich RD; Penfold ME; Zhang P; Powers J; Summers BC; Miao Z; Zhao B; Jalili A; Janowska-Wieczorek A; Jaen JC; Schall TJ
J Immunol; 2009 Sep; 183(5):3204-11. PubMed ID: 19641136
[TBL] [Abstract][Full Text] [Related]
36. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1α in MSCs.
Liu H; Xue W; Ge G; Luo X; Li Y; Xiang H; Ding X; Tian P; Tian X
Biochem Biophys Res Commun; 2010 Oct; 401(4):509-15. PubMed ID: 20869949
[TBL] [Abstract][Full Text] [Related]
37. Expression of chemokines and chemokine receptors in brain tumor tissue derived cells.
Razmkhah M; Arabpour F; Taghipour M; Mehrafshan A; Chenari N; Ghaderi A
Asian Pac J Cancer Prev; 2014; 15(17):7201-5. PubMed ID: 25227814
[TBL] [Abstract][Full Text] [Related]
38. Expression of CXCR4 and CXCR7 in papillary thyroid carcinoma and adjacent tissues and their relationship with pathologic indicators of tumor aggressiveness.
Cao X; Zhu J; Li X; Ma Y; He Q
Endocr J; 2022 Feb; 69(2):189-197. PubMed ID: 34588386
[TBL] [Abstract][Full Text] [Related]
39. Coexpression of EGFR and CXCR4 predicts poor prognosis in resected pancreatic ductal adenocarcinoma.
Wu H; Zhu L; Zhang H; Shi X; Zhang L; Wang W; Xue H; Liang Z
PLoS One; 2015; 10(2):e0116803. PubMed ID: 25679210
[TBL] [Abstract][Full Text] [Related]
40. Computer-aided assessment of the chemokine receptors CXCR3, CXCR4 and CXCR7 expression in gallbladder carcinoma.
Yu X; Lu W; Ng CW; Xu S; Wu Y; Chen S; Gao Y; Zhang Y; Zhang Q; Xu Y; Liu Y; Li S
J Cell Mol Med; 2020 Jul; 24(13):7670-7674. PubMed ID: 32512633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]